Filip Janku

Chief Medical Officer

Filip Janku (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $882K of GLUE (41,845 sh across 2 lots, as filed), executed Jun 23.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.3M

shares × price, as filed

Last traded

Jun 30

Filed Jul 1

Median ADV $21.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

GLUE

Monte Rosa Therapeutics, Inc. GLUE · 0 buys · 4 sells 4 filings

Recent filings

GLUESALE Monte Rosa Therapeutics, Inc. View filing → $132K
5,407 sh × $24.50
Exec Jun 30
Filed Jul 1 · 4:57 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $138K
6,000 sh × $22.95
Exec Jun 29
Filed Jun 30 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $882K
41,845 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $179K
9,189 sh × $19.50
Exec Feb 23
Filed Feb 24 · 5:30 PM ET